Navigation Links
Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator

HYDERABAD, India, July 14, 2014 /PRNewswire/ -- Clinicians at a leading cancer center in India have become the first in the country to commence advanced lung, liver and brain radiotherapy treatments using an upgraded Clinac® medical linear accelerator from Varian Medical Systems (NYSE: VAR). The accelerator has been enhanced with High Intensity Mode dose delivery capability, which is allowing doctors at Yashoda Cancer Institute to shorten treatment times and deliver stereotactic body radiotherapy and stereotactic radiosurgery for hard to treat tumors.

Stereotactic body radiotherapy and stereotactic radiosurgery involve delivering the total dose in fewer treatment sessions, with a greater portion of the dose delivered each session. This means conventional treatment times of five to six weeks can be reduced to just a few days. At Yashoda, stereotactic treatments are used for lung, liver, spinal and cranial treatments.

"We are a high volume center treating up to 20 stereotactic radiosurgery patients each month and by using the new High Intensity Mode we are able to treat these patients in a conventional treatment slot of about 15 minutes," says Dr. G. S. Rao, managing director of Yashoda Cancer Institute. "This is really pretty amazing and would have been unheard of a few years ago."

Dr. Rao said the High Intensity Mode has an especially important role to play for elderly lung cancer patients who are considered inoperable, offering them an alternative to surgery. The patients also benefit, he says, from their total dose being delivered in fewer treatment sessions. "This greatly reduces the number of times the patient needs to visit the hospital meaning they can get back to their normal routine in a much shorter time," said Dr. Rao.

Yashoda combines the higher delivery doses offered by the High Intensity Mode upgrade with image-guided RapidArc® radiotherapy, which the hospital began delivering in 2008, making it the first in Asia to do so. With RapidArc, the machine quickly delivers the treatment while continuously rotating around the patient, and the beam is constantly shaped and reshaped during the rotation to match the shape and size of the tumor.

Yashoda Cancer Institute hosted a seminar on High Intensity Mode Radiosurgery at the Hyatt Park Hotel in Hyderabad yesterday. Clinicians from across Asia attended the event to share experiences and hear from some the leading exponents in radiosurgery from across the world. The inauguration ceremony was headed by the Honorable First Chief Minister of Telangana State, Sri K. Chandrasekhar Rao Garu.   

"Varian is the world leader in radiotherapy and radiosurgery technology and we have pioneered high intensity dose delivery for our family of medical linear accelerators, enabling clinicians to deliver up to 2400 monitor units of radiation per minute when appropriate," says Ashok Kakkar, Varian's senior managing director in India. "That delivery speed is unmatched in the industry. Treating patients with high intensity beams requires careful and precise patient setup and monitoring, which is aided by our robotically controlled image guidance solution."

"Around the world, as at Yashoda Institute, these advanced capabilities are enabling fast and precise treatments for a range of indications, particularly lung and liver cancer that have traditionally been difficult to treat curatively with traditional radiotherapy."

He said thousands of installed Varian Clinac linear accelerators are potential candidates for upgrades with High Intensity Mode technology and the clinical advantages this technology brings.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing software and workstations for X-ray imaging in medical, scientific, and industrial applications, and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications.  Varian Medical Systems employs approximately 6,500 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit or follow us on Twitter.

SOURCE Varian Medical Systems
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Publishes Lung Cancer Patient Management Study
2. Improving quality and access to advanced cancer care in India and South Asia
3. Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment
4. Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer
5. CRLX101 Meets Primary Endpoint in Phase 2 Clinical Trial in Relapsed Ovarian Cancer
6. arGEN-X Starts Phase Ib Expansion Cohorts With ARGX-110, a Novel Anti-CD70 Antibody, in Cancer Patients
7. QIAGEN and Exosome Diagnostics to Develop First-In-Class, Non-Invasive Diagnostics for Key Genetic Biomarkers in Lung and Other Cancers
8. Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds
9. Researchers Develop Tool To Determine Individual Risk Of Prostate Cancer Overdiagnosis
10. Lilly Oncology On Canvas: Expressions of a Cancer Journey Reaches Important Milestone With 2014 Competition
11. Loyola, Notre Dame Join Forces Against Cancer
Post Your Comments:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):